One of the key reasons of our success in transforming this organisation multiple times was our approach of efficiently allocating capital across our business portfolio. Throughout our journey of last 28 years, we have always remain committed towards efficiently allocating capital while undertaking controlled risk, to consistently generate higher profitability and deliver superior shareholder returns.
Since the sale of Domestic Formulations business, we have been extremely efficient in allocating our capital to existing as well new businesses for funding their organic and inorganic opportunities. Our significant improvement in growth and profitability is a clear testimony of this effective allocation. During the period, we also exited few businesses that were either non-strategic/non-core in nature or required investments for a longer time horizon, involving higher risk.
~₹15,000 CRORES REALISED (NET OF TAXES) FROM ABBOTT ON SALE OF OUR DOMESTIC FORMULATIONS BUSINESS
CASH FLOW REALISED FROM OUR OPERATIONS OVER LAST FEW YEARS
KEY CAPITAL ALLOCATIONS
Capital returned to shareholders through